Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree Wharfrat. Investors who buy prior to the filings will have greater gains than those who only buy companies that finally do become current. Those who wait until filings come out, although they pay a much higher price and are consequently likely to get fewer shares, reduce their risk on such investments. There are pros and cons to each strategy.
I agree with you Wingtrade. Pink current is likely all UNVC needs, but I am going by other reverse merger stocks who go that extra mile. My point is that if Dalton goes for the QB status, he is doing so for a very good reason. Otherwise, it would seem to be a waste of money and time.
Junebug, I still think Kim is the CEO of the Pennsylvania subsidiary. If not, then I just don't know. Kim Oshinski is listed as a CEO of AGRiMED. So, she must be CEO of something to do with AGRiMED. However, the write-up I just posted indicates Bruce Goldman is the CEO of AGRiMED Industries incorporated in Maryland.
Materials provided by Stanford University Medical Center. Original written by Bruce Goldman. Note: Content may be edited for style and length.
The jury's still out on rock 'n' roll. But the link between sex and at least one drug, marijuana, has been confirmed.
A study by investigators at the Stanford University School of Medicine indicates that, despite concerns among physicians and scientists that frequent marijuana use may impair sexual desire or performance, the opposite appears more likely to be the case.
The findings, to be published online Oct. 27 in the Journal of Sexual Medicine, are based on an analysis of more than 50,000 Americans ages 25-45. And they're unambiguous.
"Frequent marijuana use doesn't seem to impair sexual motivation or performance. If anything, it's associated with increased coital frequency," said the study's senior author, Michael Eisenberg, MD, assistant professor of urology. The lead author is Andrew Sun, MD, a resident in urology.
Hint of a causal connection
The study does not establish a causal connection between marijuana use and sexual activity, Eisenberg noted. But the results hint at it, he added. "The overall trend we saw applied to people of both sexes and all races, ages, education levels, income groups and religions, every health status, whether they were married or single and whether or not they had kids."
The study is the first to examine the relationship between marijuana use and frequency of sexual intercourse at the population level in the United States.
"Marijuana use is very common, but its large-scale use and association with sexual frequency hasn't been studied much in a scientific way," Eisenberg said.
According to the National Institute on Drug Abuse, more than 20 million adult Americans are current marijuana users. With the drug's legalization for medical or recreational use in 29 states, that number is climbing. But despite marijuana's growing status as a recreational drug, its status as a procreational drug remains ambiguous: On one hand, there are reports of erectile dysfunction in heavy users, and rigorous studies have found reduced sperm counts in men who smoke it; on the other hand, experiments conducted in animal models and humans indicate that marijuana stimulates activity in brain regions involved in sexual arousal and activity.
Looking at survey responses
To arrive at an accurate determination of marijuana's effect on intercourse frequency, Eisenberg and Sun turned to the National Survey of Family Growth, sponsored by the federal Centers for Disease Control and Prevention. The survey, which provides data pertaining to family structures, sexual practices and childbearing, reflects the overall demographic features of the U.S. population. Originally conducted at regular intervals, the survey is now carried out on an annual basis. It explicitly queries respondents on how many times they've had intercourse with a member of the opposite sex in the past four weeks, and how frequently they've smoked marijuana over the past 12 months.
The investigators compiled answers to those questions for all years since 2002, when the survey first began collecting data on men as well as women. They included data from respondents ages 25-45 and excluded a small percentage (fewer than 3 percent) of respondents who had failed to answer one or more relevant questions.
In all, Eisenberg and Sun obtained data on 28,176 women averaging 29.9 years of age and 22,943 men whose average age was 29.5. They assessed these individuals' self-reported patterns of marijuana use over the previous year and their self-reported frequency of heterosexual intercourse over the previous four weeks.
Some 24.5 percent of men and 14.5 percent of women in the analysis reported having used marijuana, and there was a positive association between the frequency of marijuana use and the frequency of sexual intercourse. This relationship applied to both sexes: Women denying marijuana use in the past year, for example, had sex on average 6.0 times during the previous four weeks, whereas that number was 7.1 for daily pot users. Among men, the corresponding figure was 5.6 for nonusers and 6.9 for daily users.
In other words, pot users are having about 20 percent more sex than pot abstainers, Eisenberg noted.
Positive association is universal
Moreover, Eisenberg said, the positive association between marijuana use and coital frequency was independent of demographic, health, marital or parental status.
In addition, the trend remained even after accounting for subjects' use of other drugs, such as cocaine or alcohol. This, Eisenberg said, suggests that marijuana's positive correlation with sexual activity doesn't merely reflect some general tendency of less-inhibited types, who may be more inclined to use drugs, to also be more likely to have sex. In addition, coital frequency rose steadily with increasing marijuana use, a dose-dependent relationship supporting a possible active role for marijuana in fostering sexual activity.
Nevertheless, Eisenberg cautioned, the study shouldn't be misinterpreted as having proven a causal link. "It doesn't say if you smoke more marijuana, you'll have more sex," he said.
https://www.sciencedaily.com/releases/2017/10/171027085539.htm
AGRIMED Announces Addition of Dr. David Dalton to Board of Directors
Greene County, Pennsylvania. (October 20, 2017) — AGRIMED, which owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis, today announced the election of Dr. David Dalton to their Board of Directors, effective immediately.
David’s impressive background will provide our Board with a wealth of experience and skills,” said Bruce Goldman, Chair of AGRIMED’s Board of Directors. “We are looking forward to his valuable contributions on a variety of significant issues.”
In addition to over 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, a chain of retail drug stores, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies: Mednet, ManagedcareRx, Sivault Systems. Dr. Dalton is presently Chairman, President, CEO of Wellness Teladoc, Pharmacy Services Inc, Health Resources Inc and Univec Inc (UNVC). Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.
Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr. Dalton will bring his expertise in Pharmaceutical Product Development to AGRiMED to assist in the development of innovative medical cannabis products for patients with unique needs.
A picture of the UNVC patch is shown on the following website (the packaging). Since this announcement, the packaging is said to be undergoing additional changes.
http://agrimedindustries.com/2017/10/20/davie-dalton-board-of-directors/
Doctor Dalton (CEO of UNVC) was added to the AGRiMED Board of Directors to oversee and develop proprietary Pharmaceutical Medical Cannabis products.
https://twitter.com/brucegoldmanAMI
This finally answers one of the board’s questions regarding who is currently the CEO of AGRiMED. I found this in the AGRiMED archives.
February 25, 2017
1
PROMINENT HOSPITAL CEO JOINS EMERGING PENNSYLVANIA MEDICAL CANNABIS COMPANY, AGRIMED INDUSTRIES, LLC
PHILADELPHIA, Pennsylvania (February 22, 2017)— AGRiMED Industries LLC, a data-driven, highly specialized medical cannabis cultivation management company, announced today the appointment of Bruce Goldman as Chief Executive Officer. Goldman will be responsible for making executive decisions that align with the vision outlined by the AGRiMED Board of Directors, maintaining and overseeing quality control, and ensuring AGRiMED’s sustainability through corporate growth.
Goldman brings over 30 years of experience in the healthcare industry and a high level of expertise in all aspects of healthcare delivery systems, managed care, healthcare policy and has played an essential role by leading organizations through major regulatory and market changes.
“Bruce is a seasoned professional who will play a key role in our growth and prosperity as a quality medical cannabis service provider,” said Sterling Crockett, Chairman of the Board and Chief Diversity Officer of AGRiMED. “He’s a visionary and I am confident in his ability to lead our team down a path of continued success in this industry as we progress as a company.”
Goldman has held a residency at the Montefiore Medical Center in the Bronx, New York, and became an Assistant Administrator at the Montefiore Medical Center for Prison Health Services on Rikers Island in Queens, New York. Additionally, Goldman relocated from New York to Washington D.C to serve as the Director of Planning for George Washington University Health Plan. He is a graduate of Yale University School of Medicine, Department of Epidemiology and Public Health, MPH, Hospital Administration and has a B.A. in Economics from Lincoln University.
Throughout his career, Goldman took on additional leadership roles as Chief Administrative Officer for Clinical Services at District of Columbia General Hospital, Assistant Hospital Director at the University of Maryland Hospital, Associate Administrator at The Hospital of the University of Pennsylvania, and Senior Associate at Brisbon and Associates, a healthcare consulting and management firm. Goldman rose to become the CEO at Harlem Hospital Medical Center in New York City and consultant and CEO at Roy Lester Schneider Hospital. Most recently, Goldman served as President and COO of Health Services for Children with Special Needs, Inc. Three years ago, he retired to pursue a new career in the medical cannabis industry to help spearhead the development of AGRiMED. The company is confident that Bruce Goldman’s attributes and expertise will advance their patient-focused mission.
“I have a deep understanding of the healthcare industry and with my past experience, I intend to educate, inform and work to provide the best care possible as it relates to medical cannabis,” said Bruce Goldman, CEO of AGRiMED Industries. “The high-quality technology and leadership behind AGRiMED puts us in the enviable position of becoming an industry leader in the medical field and I look forward to being a part of a team that is dedicated to progressive healthcare.”
AGRiMED is currently undergoing the submission process to obtain a registered license through the Pennsylvania Department of Health to cultivate and process medical cannabis in the Southwestern region of the state of Pennsylvania. AGRiMED Industries is headquartered in Silver Spring, Maryland. More information about AGRiMED Industries is available on the company’s website, www.agrimedindustries.com.
For additional information or to coordinate an interview with a representative at AGRiMED Industries, please contact Jessica Olenik at Neff Associates directly at (215) 627-4747 x 107 or via email at jo@neffassociates.com.
https://agrimedindustries.com/2017/02/25/prominent-hospital-ceo-joins-emerging-pennsylvania-medical-cannabis-company-agrimed-industries-llc/
Good points doncamel. I suspect you bought in at an opportune time, and since the share structure is low and without signs of dilution, this ticker moves quickly. Best of luck to you, and good to see you here.
doncamel, Sterling Crockett is a real mover and shaker who gets things done. After 911, Crockett won a contract to help rebuild the Pentagon, and has been very active helping injured veterans. Crockett's motivation for getting involved in medical marijuana stems from the time his daughter was diagnosed with cancer. After receiving traditional medical help and not getting much better, Crockett tried cannabis treatments. Today, Crockett's daughter is said to be cancer free.
A little due diligence:
Many people may not know that Sterling Crockett is the founder of AGRiMED, as well as one of the founders of Green Thumb Industries in Maryland (you may have heard about this mega marijuana company since it just did a reverse merger with a Canadian company). Sterling Crockett moved to Florida after the Pennsylvania grow and processing facility was approved, and we were told at the time Crockett intended to work with Florida legislators to get laws changed in favor of marijuana. However, Sterling Crockett did not stop there. Crockett is working with Congress to change marijuana laws nationwide, and is working with hospitals and research facilities to implement research programs aimed at discovering the many benefits derived from cannabis.
This board has discussed the many AGRiMED companies found in other neighboring states, and could they be part of our AGRiMED. These are good questions, and should be pursued. However, one should also ask if perhaps there are other marijuana companies started or founded by Sterling Crockett that might one day also be folded into this entity.
Example:
SATIVEO OF NY, LLC
SATIVEO OF NY, LLC is an entity registered at NEW YORK county with company number 5268379. C/O STERLING CROCKETT located at the address 137 Central Park North New York, New York, 10026. Company was incorporated on January 17, 2018. Current status of the company is active.
https://www.company-detail.com/company-sativeo-of-ny-llc-5268379
There is a SATIVEO LLC located in South Carolina registered as a marijuana and HEMP company.
Huge study shows cancer benefits, limitations of antiretroviral therapy for HIV
Author Bruce Goldman (Chair of the Board of Directors, AGRiMED Industries) Published on June 13, 2018
The preferred treatment for HIV can reduce cancer incidence among infected individuals, a new study shows. However, on a more sobering note, even individuals for whom the therapy is successful retain elevated rates of cancer over those who are not infected.
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, it results in radical improvement in health and life expectancy for HIV-positive individuals.
New confirmation, at least with respect to cancer, comes in the form of a very large study comparing health outcomes of 42,441 HIV-positive U.S. armed-forces veterans with 104,712 HIV-negative vets over a 16-year period between 1999 and 2015. The new study was "the first to examine the effects of prolonged periods of viral suppression and potential cancer prevention benefits," says Stanford population-health scientist Lesley Park, PhD, of the study, which was funded by the National Institutes of Health, led by Park and published in Annals of Internal Medicine.
Some 9 percent of the HIV-positive veterans followed in the study eventually contracted cancer of one type or another, as opposed to 6.8 percent of uninfected participants. Drilling down, the investigators observed substantially lower cancer rates among HIV-infected individuals who had achieved long-term viral suppression than among those who hadn't.
More than half of the HIV-positive individuals in the study achieved long-term viral suppression at some point. But even among HIV-positive patients who had attained long-term viral suppression, overall cancer rates remained about 50 percent higher than those of uninfected veterans.
In prior work, Park and her colleagues have shown that the prevalence of oncogenic, or cancer-causing, viral infections is extraordinarily high among people infected with HIV. In the new study, successful antiretroviral therapy profoundly improved the prognosis for such people. Rates of certain virally induced cancers whose occurrence in an HIV-positive individual is sufficient to confer an AIDS diagnosis (for example, Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) plummeted among those HIV-positive veterans whose antiretroviral therapy had succeeded in inducing long-term viral suppression.
Meanwhile, HIV-positive veterans lacking any such suppression developed these cancers at more than 20 times the rate of uninfected veterans. Still, even HIV-infected veterans attaining long-term suppression developed such cancers more than twice as often as uninfected vets did.
The study also showed drops in rates of several cancers that, while not specifically considered markers of AIDS, are associated with viral causation (for example, melanoma, leukemia and cancer of the lung or larynx). Absent long-term viral suppression, HIV-positive patients developed these cancers at nearly four times the rate of uninfected individuals; among those with long-term suppression, the rate was below three times that of uninfected people.
One upshot of the study, according to Park: "Clinicians and patients should be even more motivated to adhere to treatment to achieve long-term viral suppression."
https://scopeblog.stanford.edu/2018/06/13/huge-study-shows-cancer-benefits-limitations-of-antiretroviral-therapy-for-hiv/
Using Medical Marijuana to Treat PTSD
Post traumatic stress disorder (PTSD) is an illness that affects more than three million Americans annually. Traditional medicines used to treat this affliction generally fall within the SSRI family which are typically used to treat depression and anxiety disorders. While these can bring relief for these specific aspects of PTSD, there are a number of symptoms that come along with the malady that may require a more all-encompassing treatment.
Here is where AGRiMED can help with our world-class medical cannabis medicines. While studies are still being conducted on illnesses like PTSD in order to better understand how to approach and treat them, cannabis has consistently proven itself as a top contender in providing relief to PTSD patients. One of the main reasons cannabis is so good at targeting the needs of PTSD patients is that it helps tremendously with those feelings of hyper-vigilance, stress, and fight-or-flight tendencies, among other things.
When looking to treat PTSD with medical marijuana, there are two directions a patient can go: a high-CBD strain or high-THC strain, though a combination of both is generally recommended to really reap the benefits of medical cannabis. For example, CBD has been shown to reduce the learned fear, along with its responses, that so often encompasses PTSD; in all, it has provided strong calming effects for PTSD patients.
On the other hand, there’s THC, which has many benefits of its own. THC is actually quite similar to anandamide, a neurotransmitter that binds itself to cannabinoid receptors and which is actually quite similar to THC itself. Also known as the “bliss molecule,” anandamide is often found in low numbers in patients suffering from PTSD. That being said, anandamide’s and THC’s similarities work for the benefit of the patient as THC can replenish a person’s anandamide levels. Beyond this wonderful benefit of THC, this specific cannabinoid has been proven time and time again to be a wonder for those suffering from sleep problems, one of the major issues facing PTSD patients. Adding a regimen of high-THC medical marijuana, especially at night, can work to lower and even eliminate night terrors that often accompany PTSD. AGRiMED formulates a variety of medical marijuana medicines for PTSD patients.
Though other methods of treatment are recommended alongside medical marijuana, such as psychotherapy or cognitive behavioral therapy, a holistic approach is the best way to tackle the illness. Medication, therapy, exercise, and a healthy diet are all important factors in the lives of recovering PTSD patients.
Regardless of whether the PTSD was incurred through combat, assault, etc., medical marijuana may just be the way to go when looking for treatment options. As medical cannabis is slowly being legalized all across the country, this effective form of treatment is a great option for any type of case, whether hard-to-treat or not. In any case, consult your healthcare professional if you think medical marijuana would benefit you.
https://agrimedindustries.com/2018/05/22/using-medical-marijuana-to-treat-ptsd/
If everything goes well Junebug, you could very well be right. If so, welcome to the one percent, it suits you. We will celebrate together.
Thank you Cheetah Man Iowa, and I wish you the very best.
Junebug, that sounds like an excellent plan. And, I know you have done your research.
For AGRiMED/UNVC investors, there are 3 things you Must Know about playing the pot market:
First bit of advice. Know your personal goals and stick to them.
Only you know what you want out of life. And, only you can apply this to how you play the markets. So, if you don’t have set goals, stop everything and make a few of them --- or at least one.
Second, don’t let a skittish herd overwhelm your rational thinking.
A dip in your holdings should not initiate panic. Nor should others’ panic set your panic buttons off.
Stocks go and stocks go down. But this usually means a good buying opportunity if you have faith in your holdings. You did do your research right?
If you said no to the above, stop what you are doing and make sure you know everything you can about what you’re holding. There is simply no substitute for good due diligence when your own money is at stake.
Third bit of advice: Don’t bet more money than you can afford to lose.
I know, this is a tired old bit of advice, but that doesn’t mean it is poor advice. Too many penny and sub-penny stock investors bet it all and then they let it ride --- eventually ending up with nothing. The fact is, stocks will rise and then they will fall, and then the good ones will rise once again --- the really good ones will rise more often then they fall, and will keep on going. So take a little off the table along the way and treat yourself or those around you to a really good time. In my opinion, you can always buy back in if the stock does not drop all that much, and if it does (stocks do correct), you can end up buying more than you had in the first place.
That’s the best way I know to protect yourself from irrational action if your position(s) take a hit. I suspect AGRiMED/UNVC will be one of the good ones, but one never knows what is just around the corner. If all goes well, this one will be one to hold for years. That would make UNVC the exception, but research seems to indicate that it could be. In fact, UNVC could be a life changer.
Just to re-cap. Today, we wait for news regarding UNVC and the partnership with AGRiMED. Since AGRiMED once again mentioned the transdermal patch as a new product soon to be introduced in yesterday’s tweet, and since we were told AGRiMED prefers the UNVC patch, it seems logical AGRiMED is referring to the UNVC patch. If AGRiMED was not impressed with Dr. Dalton and the UNVC patch, why would AGRiMED appoint Dr. Dalton to their Board of Directors, and then promote him to Vice Chairman of the Board of Directors in rapid order right after AGRiMED announced their partnership? Did I mention that AGRiMED actually announced this partnership and not Univec? Did I mention that AGRiMED specifically mentioned the UNVC patch in this partnership announcement?
In addition, nearly everyone in management at AGRiMED has connections of some sort with the military and with the treatment of various problems associated with veteran healthcare. AGRiMED has posted their plan to treat PTSD, Opioid addiction, cancers, and numerous other maladies veterans as well as non-veterans are prone to suffer from. So, one thing I am looking for and frankly hoping for is a little talk very soon about a government contract or two. I suspect a contract will not happen right away, but some mention of this would be helpful in my opinion.
Now many on this board express the hope and strong desire for a reverse merger between AGRiMED and Univec as a low cost and expedited means of going public. There is no doubt such a move would catapult UNVC stock price. And, a big government contract would certainly make a reverse merger very attractive to AGRiMED, provided the UNVC patch is part of that equation.
This is just my two cents. However, there are many other possibilities, and no one really knows what AGRiMED intends to do.
Should the above scenario occur, I suspect many would need to raise their expectations of where this partnership might go, and how much early investors might prosper. Good times ahead here folks.
AGRiMED? @Agrimedi 5 minutes ago NEW TWEET
Our lineup of #medicalcannabis will include #CO2 oils and #THC and #CBD tinctures, vapor carts, transdermal patches, and capsules. #ComingSoon
Our lineup of #medicalcannabis will include #CO2 oils and #THC and #CBD tinctures, vapor carts, transdermal patches, and capsules. #ComingSoon
— AGRiMED (@Agrimedi) July 11, 2018
Thank you Junebug, much appreciated.
If UNVC ever does get current, I wonder what level Dalton intends to obtain --- OTC QB? QB status is not cheap --- Looks like $14,500 to start then an annual fee of $12,000.
I have friends who will only buy penny stocks that are QB or QX level. They think it is crazy to buy stocks that are non-filers, even though these stocks often post the highest gains.
https://www.otciq.com/fees
QB status often brings in more buyers and the type of buyers that only buy upper level types of stocks --- less risk and therefore higher volume.
Very rarely do you ever see a “non-filer stop sign stock” go to QB status. Usually the CEO's don't want to pay the extra fee every year. The cost's to keep a company current are already high enough. However, if a company is planning on a reverse merger, then the extra cost may be justified to protect the merging company. Although I am not a big advocate for a reverse merger between AGRiMED and UNVC, I can see the advantages of doing so --- particularly the ease of raising additional capital.
When to Register?
Registration is required within 5 days of introducing product into commercial distribution. Annual renewal of registration must occur between October 1 and December 31 of each year.
BeerIsGood, please note, AGRiMED/UNVC has not introduced their new cannabis patch to the market place... yet.
Perhaps this is the reason the UNVC patch was not renewed:
Do I Need to Register?
With certain exemptions, any establishment engaged in the manufacture, repacking, relabeling, or salvaging of a drug product for commercial distribution is required to register with FDA.
Some exemptions include (but not limited to):
Pharmacies that:
o Operate in conformance with all applicable local laws regulating the practice of pharmacy and medicine;
o Regularly engage in dispensing prescription drugs upon a valid prescription; and
o Do not manufacture, repack, relabel, or salvage drugs other than in the regular course of their business of dispensing or selling drugs at retail.
• Hospitals, clinics, other health care entities, and public health agencies that:
o Operate establishments in conformance with all applicable local laws regulating the practice of pharmacy and medicine;
o Regularly engage in dispensing prescription drugs upon a valid order or prescription;
o Do not manufacture, repack, relabel, or salvage drugs other than in the regular course of their practice of pharmacy, including dispensing;
• Practitioners who are licensed by law to prescribe or administer drugs and who manufacture, repack, relabel, or salvage drugs solely for use in their professional practice;
• Manufacturers, repackers, relabelers, or salvagers who manufacture, repack, relabel, or salvage drugs solely for use in research, teaching, or chemical analysis and not for sale;
• Manufacturers, repackers, and relabelers of harmless inactive ingredients such as excipients, colorings, flavorings, emulsifiers, lubricants, preservatives, or solvents that become components of drugs;
• Carriers, in their receipt, carriage, holding, or delivery of drugs in the usual course of business as carriers; and
• Storage facilities which do not perform any manufacturing function.
https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/drugregistrationandlisting/ucm078801.htm
Excellent Junebug. Thank you. Maybe BeerIsGood can also find this information?
Thanks Junebug, and I remember that being posted too. I imagine these labeler codes expire after a while if they are not renewed.
I will see if I can dig this information up again, it has been posted numerous times. I am surprised you have not been able to find it. I suspect you will find the information listed under UNVC. I suspect it is also listed in the stickies.
I agree Cheetah Man Iowa. The people who have been digging have found encouraging information regarding AGRiMED, UNVC, and the possible connections.
You are not listening BeerIsGood. People on this very board have contacted AGRiMED Industries, they talked to Mark Kaminski who said he was the Chief Creative Officer and most recently he told a board member he is now the Chief Marketing Officer, and they were told AGRiMED prefers the UNVC patch. If you look back at UNVC, you can find UNVC developed a patch for "nicotine and other medications" back a few years ago. AGRiMED put out the press release announcing the partnership with UNVC and directly talked about the patch.
Why don't you contact AGRiMED BeerIsGood? Also, please tell us why AGRiMED appointed Dr. Dalton to their Board of Directors after they announced this partnership --- and then promoted Dalton to Vice Chair of the Board. Doesn't it make sense that Dalton has something to offer? I would like to hear your explanation.
Wingtrade, is this the first security you are in that is attempting to become current? I have been in several that have taken a long time. I am told it is not easy, and that it is expensive. I am also told that delays are common. On every board where becoming current is the goal, people do not wish to wait, and many simply do not. Unfortunately, those people lose out or pay dearly to get back in when the security does become current.
Conversely, some securities never do become current. The wait is for not. That is the reason many people consider these stocks to be a gamble.
I have never seen where AGRiMED has a transdermal patch --- have you? If so, then this must be something new. In fact, people who did contact AGRiMED claim Univec has the patch that they prefer. If you had contacted AGRiMED yourself, you may have had that same response from the management at AGRiMED.
We both are Junebug.
AGRiMED Industries Cannabis Partnership with Univec
GREENE COUNTY, Pa., Oct. 2, 2017 — AGRiMED, which owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis, today announced a unique and innovative partnership with Univec, Inc (UNVC), a specialty pharmaceutical company to manufacture and distribute its medical cannabis transdermal patch for treatment and relief of approved medical conditions. A transdermal patch adheres or sticks to the skin and delivers a specific dose of medication through the skin and into the bloodstream.
AGRiMED Industries Chief Executive Officer (CEO) Sterling Crockett said, “Today’s announcement is consistent with our philosophy of connecting those in need with innovations that heal cleanly, comfortably and sustainably.” He added, “We are excited about working with Univec and look forward to sharing the benefits of this partnership with the people of Pennsylvania and beyond.”
Dr. David Dalton, Univec’s CEO said “Combining Univec’s medical and pharmaceutical expertise with AGRiMED Industries’ innovative approach to the cannabis marketplace and commitment to its patient focused services makes for a very powerful partnership to expand the treatment options available to the medical community.”
https://agrimedindustries.com/2017/10/04/agrimed-industries-cannabis-partnership-univec/
Just to recap recent marijuana news, and how it might effect AGRiMED/UNVC.
Last Monday, the U.S. Senate approved a bill to allow military veterans to receive recommendations for medical marijuana from doctors at the Department of Veterans Affairs (VA) --- the bill passed by a vote of 86 to 5, which is a pretty darn good showing.
The next step is a conference committee made up of House representatives and Senators who will reconcile each chamber’s bill into the final legislation that makes it to the President.
Also last Monday, the FDA gave approval for the use of cannabidiol to treat certain types of seizures (this was posted on this board).
FDA Commissioner Scott Gottlieb released a statement from the agency on the importance of a pathway to vet therapies derived from marijuana and its components.
“The FDA will continue to support rigorous scientific research on potential medical treatments using marijuana and its components that seek to be developed through the appropriate scientific channels,” says Dr. Gottlieb.
Separately, the Senate and the FDA have given cannabis-based therapies a major thumbs-up.
This is great news for the pharmaceutical companies working on new therapies based on the compounds found in marijuana, and it’s an even bigger win for the patients.
There are plenty of great success stories surrounding the use of medical marijuana to help treat veterans with post-traumatic stress disorder (which could be treated with the UNVC patch).
All-in-all, pretty good news for a company called AGRiMED intent on producing medical therapies derived from cannabis products, and for a company called Univec who has recently partnered with AGRiMED to product the UNVC patch.
Very good wharfrat. This means becoming current and any elaboration about the partnership agreement between AGRiMED/UNVC is considered a material event. Certainly anything regarding a merger or reverse merger would also qualify for an 8k. In other companies who have become current and developed business ties, a flurry of 8Ks were released.
Wharfrat, your question or that action is problematic. UNVC must inform investors of any material event, and going into production on UNVC patches is most definitely a material event for UNVC shareholders. In fact, anything that generates or detracts from revenue (the mother's milk of share appreciation) is a material event. So my answer is that going into patch production without UNVC filings being released is not likely.
What we are likely to see is several form 8s in rapid order. IMO
AGRiMED is very secretive. I assume they will inform people of what they are doing when they feel the time is right for them. In my opinion, this unwillingness to inform the public is a strange way to run a business, but they may have their reasons, and they could spring something really big on us at any time.
Product awareness is typically a high priority for any company --- public or private. Keeping the public aware and informed of what a company has to offer is normally one of their highest goals, and this information flow is what drives business. So, I feel they will (must) start informing us at some point. Perhaps this is a way of getting a leg up on their competition?
That is a good point Junebug. Dr. David L. Dalton (CEO of UNVC) was appointed to the AGRiMED Board of Directors, and was later promoted to Vice Chairman of the Board of Directors. These moves not only affirm confidence in Dalton and UNVC, but it also means Dalton is involved in the day to day decision making at AGRiMED. I don't like the silence any more than anyone else, but the building blocks are definitely in place.
You are right Junebug, we do need UNVC to get up and going. However, the hiring at Carmichael does show that AGRiMED is getting ready to do something, and soon. As far as we know, the partnership between AGRiMED and Univec is still in tact, and that should mean good things for both companies.
It looks like AGRiMED Carmichael is gearing up.
AGRiMED CAREERS
Join the Team Transforming the Cannabis Industry
Thank you for your interest in AGRiMED! We are looking for smart, agile individuals like you to help us achieve our mission of transforming the cannabis healthcare industry in America.
Equal Employment Opportunity/Affirmative Action
AGRIMED Industries is committed to providing equal employment opportunities for all job candidates and employees without regard to unlawful consideration of race, color, religion, sex, national origin, age, disability, veteran status or any other status protected by applicable law. This commitment extends to all terms and conditions of employment. In addition, AGRiMED has developed affirmative action plans consistent with federal law to further the principle of equal employment opportunity.
Administrative Assistant
Cultivation/Grow Room Specialist, Carmichaels
Delivery Driver
Extraction Lab Technician
Fulfillment Specialist
Packaging/Trim Room Specialist
https://agrimedindustries.com/careers/
It’s a big day in Vermont. Vermont becomes the ninth state to legalize recreational marijuana, but with no provisions in the law for pot shops. July 1, 2018 will go down in Vermont’s history as the day the state officially stopped punishing adults for consuming marijuana.
Adult Residents of Vermont can now legally possess, consume, and grow limited amounts of marijuana. AGRiMED/UNVC are you listening? A whole new market has just opened up for your exploitation. However, new markets are only as good as the effort put forth to develop them.
Vermont Marijuana Festival. A water truck and sprinklers are last-minute additions thanks to hot weather at a Vermont festival celebrating the legalization of marijuana. Ain't life wonderful?
https://kdvr.com/2018/07/01/vermont-becomes-ninth-state-to-legalize-recreational-marijuana/
WOW! A receptionist job pays pretty good at AGRiMED Industries. This job posting proves AGRiMED in Pennsylvania is hiring and growing.
Thanks GREEN MAKER
We know Sterling Crockett opened a new marijuana business in South Carolina (the company is called Sativeo). Groundbreaking research in South Carolina discovered the following:
Nigella sativa (also known as the Black Seed because of the distinctive black coloration of its seeds) is known for its remarkable healing powers. It has been used for centuries all over the world to treat many ailments such as headaches, nasal congestion, toothache, intestinal worms, asthma, diarrhea and dyslipidaemia, and much more. It has also been reported to as a diuretic to promote menstruation and increase milk production in women.
Ibn Sina, a famous philosopher from the medieval times and the author of the most famous book in the field of medicine: "The Canon of Medicine", claims that the Black Seed is good for intestinal parasites and worms and a good remedy for poisonous bites and stings.
Nigella sativa can help cure cancer!
An amazing discovery was made in South Carolina at the Cancer Research Laboratory of Hilton Head Island, where experimental research proved that Nigella sativa oil had a sucess on tumor therapy without causing the negative side effects caused by chemo therapy. It was actually found that N.sativa increased the growth rate of bone marrow by approximately 250%. Not only that but it was also discovered that N.sativa suppresses tumor growth by 50%!
Nigella sativa is rich in nutritional values!
Black Seed has a high nutritional value. It is very rich in unsaturated fatty acids, Arginie (good for infant growth) and carotene, which is converted to vitamin A; needed for vision, and also helps to act as an anti-cancer vitamin. N.sativa also contains a non-starchy polsaccharide substance (fiber) which is a useful dietary supplment.
http://bioweb.uwlax.edu/bio203/s2009/shaheen_baya/Medicinal%20Uses.htm